2Shilo L, Hadari R, Kovatz S, et al. Appropriateness of nitrate use in a general medicine population. Ann Pharmacother,2001,35 :1339-42.
3Okamoto MP,Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy, 2001,21 : 1337-1344.
4Huse DM,Roht LH,Alpert JS,et al. Physicians, knowledge,attitudes,and practice of pharmacologic treatment of hypertension. Ann Pharmacother ,2001,35 : 1173-1179.
5Verleden GM, De VP. Assessment of asthma severity and treatment by GPs in Belgium:an Asthma Drug Utilization Reseaw.h Study(ADUR).Respir Med ,2002 ,96 :170-177.
6Vermeire PA, Rabe KF,Soriano JB,et al. Asthma control and diffeaences in management practices across seven European countries. Respir Med,2002,96 : 142-149.
7卞如濂.吸入型糖皮质激素安全性与有效性比较[J].哮喘杂志,2002,8(2):98-99.
8Werner HA.Status asthmaticus in child[J].Chest,2001,119(6):1 913-1 929.
9National Heart,Lung,and Blood Institute,National Institute of Health.Global initiative for asthma: global strategy for asthma management and prevention,NHLBI/WHO workshop report Mar 1993[M].Washington DC:NIH,1995.2-8;120-137.
7Mark Fitz Gerald. Global initiative for asthma ( 2012 ) [DB/ OL]. http://www.ginasthma.org, 2012.
8Wong GW, Kwon N, Hong JG. Pediatric asthma control in Asia: phase 2 of the asthma insights and reaality in Asia-Pacific (AIRIAP 2 ) survey [J]. Allegy, 2013, 68 (4) : 524-530.
9Chrystyn H, Small M, Milligan G. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD [J]. Respir Med, 2014, 108 ( 2 ) : 358-365.
10Voshaar T, Spinola M, Linnane P. Comparing usability of NEXThaler with other inhaled corticosteroid/long-acting fl2- agonist fixed combination dry powder inhalers in asthma pa- tients [J]. Aerosol Med Pulm Drug Deliv, 2013, 12: 3.
